PubMed

Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Rosove MH, Brewer PM.

Ann Intern Med. 1992 Aug 15;117(4):303-8.PMID: 1637025 [PubMed - indexed for MEDLINE]Related articles

The management of thrombosis in the antiphospholipid-antibody syndrome.

Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR.

N Engl J Med. 1995 Apr 13;332(15):993-7.PMID: 7885428 [PubMed - indexed for MEDLINE]Related articlesFree article

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.

Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN.

Arch Intern Med. 1997 Oct 13;157(18):2101-8.PMID: 9382667 [PubMed - indexed for MEDLINE]Related articles

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T.

J Thromb Haemost. 2005 May;3(5):848-53.PMID: 15869575 [PubMed - indexed for MEDLINE]Related articles

Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GR.

Arch Intern Med. 2002 May 27;162(10):1164-9.PMID: 12020188 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of antiphospholipid antibody syndrome: a systematic review.

Lim W, Crowther MA, Eikelboom JW.

JAMA. 2006 Mar 1;295(9):1050-7. Review.PMID: 16507806 [PubMed - indexed for MEDLINE]Related articlesFree article

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.

Wahl DG, Bounameaux H, de Moerloose P, Sarasin FP.

Arch Intern Med. 2000 Jul 10;160(13):2042-8.PMID: 10888978 [PubMed - indexed for MEDLINE]Related articlesFree article

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

Clin Ther. 2004 Jul;26(7):1149-59.PMID: 15336480 [PubMed - indexed for MEDLINE]Related articles

Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.

Brunner HI, Chan WS, Ginsberg JS, Feldman BM.

J Rheumatol. 2002 Mar;29(3):490-501.PMID: 11908562 [PubMed - indexed for MEDLINE]Related articles

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP; APASS Investigators.

JAMA. 2004 Feb 4;291(5):576-84.PMID: 14762036 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments.

Rivier G, Herranz MT, Khamashta MA, Hughes GR.

Lupus. 1994 Apr;3(2):85-90.PMID: 7920619 [PubMed - indexed for MEDLINE]Related articles

[The antiphospholipid syndrome, an update]

Alonso Santor JE, Inglada Galiana L, Pérez Paredes G.

An Med Interna. 2007 May;24(5):242-8. Review. Spanish. PMID: 17907891 [PubMed - indexed for MEDLINE]Related articles

[Aspirin and antiphospholipid syndrome]

Hachulla E, Piette AM, Hatron PY, Blétry O.

Rev Med Interne. 2000 Mar;21 Suppl 1:83s-88s. Review. French. PMID: 10763209 [PubMed - indexed for MEDLINE]Related articles

[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]

Míka P, Behounek J, Skoták M, Nevsímal L.

Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44. Czech. PMID: 15456102 [PubMed - indexed for MEDLINE]Related articles

Antiphospholipid syndrome: clinical and therapeutic aspects.

Vlachoyiannopoulos PG, Tsiakou E, Chalevelakis G, Raptis SA, Moutsopoulos HM.

Lupus. 1994 Apr;3(2):91-6.PMID: 7920620 [PubMed - indexed for MEDLINE]Related articles

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.

Hereng T, Lambert M, Hachulla E, Samor M, Dubucquoi S, Caron C, Launay D, Morell-Dubois S, Queyrel V, Hatron PY.

Lupus. 2008;17(1):11-5.PMID: 18089677 [PubMed - indexed for MEDLINE]Related articles

Thrombophilia, clinical factors, and recurrent venous thrombotic events.

Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR.

JAMA. 2005 May 18;293(19):2352-61.PMID: 15900005 [PubMed - indexed for MEDLINE]Related articlesFree article

Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis.

Colì L, Donati G, Cianciolo G, Raimondi C, Comai G, Panicali L, Nastasi V, Cannarile DC, Gozzetti F, Piccari M, Stefoni S.

J Vasc Access. 2006 Jul-Sep;7(3):118-22.PMID: 17019663 [PubMed - indexed for MEDLINE]Related articles

[Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]

Marai I, Levi Y, Godard G, Shoenfeld Y.

Harefuah. 2001 Jun;140(6):495-500, 565. Hebrew. PMID: 11420848 [PubMed - indexed for MEDLINE]Related articles

The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.

Deerhake JP, Merz JC, Cooper JV, Eagle KA, Fay WP.

J Thromb Thrombolysis. 2007 Apr;23(2):107-13.PMID: 17221327 [PubMed - indexed for MEDLINE]Related articles